Abstract: The present invention relates to identification of a gene that is inactivated in a mucolipidosis condition. In particular, the invention concerns mutations that disrupt a mucolipin, preferably MCOLN1, in mucolipidosis IV. Recombinant nucleic acids encoding mutant forms of MCOLN1, oligonucleotides specific for such mutations, and diagnostic and therapeutic applications related to these discoveries, are also contemplated.
Type:
Application
Filed:
May 8, 2001
Publication date:
April 3, 2003
Applicant:
The ML4 Foundation and President and Fellows of Havard College
Inventors:
Ehud Goldin, Susan A. Slaugenhaupt, Mei Sun, James S. Acierno